| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |